193 related articles for article (PubMed ID: 26298725)
1. Overexpression of TRIP6 promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR) via regulating nuclear p27(Kip1) expression in non-Hodgkin's lymphoma.
Miao X; Xu X; Wu Y; Zhu X; Chen X; Li C; Lu X; Chen Y; Liu Y; Huang J; Wang Y; He S
Tumour Biol; 2016 Jan; 37(1):1369-78. PubMed ID: 26298725
[TBL] [Abstract][Full Text] [Related]
2. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract][Full Text] [Related]
3. TRIP6 regulates p27 KIP1 to promote tumorigenesis.
Lin VT; Lin VY; Lai YJ; Chen CS; Liu K; Lin WC; Lin FT
Mol Cell Biol; 2013 Apr; 33(7):1394-409. PubMed ID: 23339869
[TBL] [Abstract][Full Text] [Related]
4. TRIP6 promotes cell proliferation in hepatocellular carcinoma via suppression of FOXO3a.
Zhao W; Dai Y; Dai T; Xie T; Su X; Li J; Zhou X; Meng K; Zhao X
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):594-601. PubMed ID: 29080747
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma.
Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S
Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594
[TBL] [Abstract][Full Text] [Related]
6. TRIP6 promotes tumorigenic capability through regulating FOXC1 in hepatocellular carcinoma.
Wang F; Zhang B; Xu X; Zhu L; Zhu X
Pathol Res Pract; 2020 Apr; 216(4):152850. PubMed ID: 32046874
[TBL] [Abstract][Full Text] [Related]
7. Silencing of CKIP-1 promotes tumor proliferation and cell adhesion-mediated drug resistance via regulating AKT activity in non-Hodgkin's lymphoma.
Zhu X; Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Liu H; He S
Oncol Rep; 2017 Jan; 37(1):622-630. PubMed ID: 27840970
[TBL] [Abstract][Full Text] [Related]
8. [Expression, localization and interrelationship of P27kip1 and cyclin D3 in non-Hodgkin's lymphoma].
Zhang DM; Lu JX; Shen AG; Chen L; He S; Shao XY; Liu HO; Cheng C
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):723-7. PubMed ID: 16620575
[TBL] [Abstract][Full Text] [Related]
9. Sam68 regulates cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) via the AKT pathway in non-Hodgkin's lymphoma.
Wu Y; Xu X; Miao X; Zhu X; Yin H; He Y; Li C; Liu Y; Chen Y; Lu X; Wang Y; He S
Cell Prolif; 2015 Dec; 48(6):682-90. PubMed ID: 26478515
[TBL] [Abstract][Full Text] [Related]
10. ENO1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphomas.
Zhu X; Miao X; Wu Y; Li C; Guo Y; Liu Y; Chen Y; Lu X; Wang Y; He S
Exp Cell Res; 2015 Jul; 335(2):216-23. PubMed ID: 26024773
[TBL] [Abstract][Full Text] [Related]
11. DIXDC1 promotes tumor proliferation and cell adhesion mediated drug resistance (CAM-DR) via enhancing p-Akt in Non-Hodgkin's lymphomas.
Ouyang Y; Zhong F; Wang Q; Ding L; Zhang P; Chen L; Wang Y; Cheng C
Leuk Res; 2016 Nov; 50():104-111. PubMed ID: 27701018
[TBL] [Abstract][Full Text] [Related]
12. [Expression and correlation of Skp2 and p27(kip1) in 92 cases of non-Hodgkin's lymphoma].
Lu JX; Zhang DM; Shen AG; Wang YC; He S; Shao XY; Liu HO; Cheng C
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):373-7. PubMed ID: 17892135
[TBL] [Abstract][Full Text] [Related]
13. Expression of small glutamine-rich TPR-containing protein A (SGTA) in Non-Hodgkin's Lymphomas promotes tumor proliferation and reverses cell adhesion-mediated drug resistance (CAM-DR).
Wang Y; Huang Y; Xu X; Tang J; Huang X; Zhu J; Liu J; Miao X; Wu Y; Yang F; Ji L; He S
Leuk Res; 2014 Aug; 38(8):955-63. PubMed ID: 24974147
[TBL] [Abstract][Full Text] [Related]
14. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR).
Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S
Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095
[TBL] [Abstract][Full Text] [Related]
15. The role of the Chaperonin containing t-complex polypeptide 1, subunit 8 (CCT8) in B-cell non-Hodgkin's lymphoma.
Yin H; Miao X; Wu Y; Wei Y; Zong G; Yang S; Chen X; Zheng G; Zhu X; Guo Y; Li C; Chen Y; Wang Y; He S
Leuk Res; 2016 Jun; 45():59-67. PubMed ID: 27101149
[TBL] [Abstract][Full Text] [Related]
16. TTPAL Promotes Colorectal Tumorigenesis by Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling.
Gou H; Liang JQ; Zhang L; Chen H; Zhang Y; Li R; Wang X; Ji J; Tong JH; To KF; Sung JJY; Chan FKL; Fang JY; Yu J
Cancer Res; 2019 Jul; 79(13):3332-3346. PubMed ID: 31018940
[TBL] [Abstract][Full Text] [Related]
17. [MicroRNA-138 regulates cell adhesion-mediated drug resistance phenotype by targeting SGTA in non-Hodgkin's lymphoma].
Wu YX; He S; Xu XH
Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):668-673. PubMed ID: 30180469
[No Abstract] [Full Text] [Related]
18. Expression of Foxo3a in non-Hodgkin's lymphomas is correlated with cell cycle inhibitor p27.
Zhao Y; Fei M; Wang Y; Lu M; Cheng C; Shen A
Eur J Haematol; 2008 Aug; 81(2):83-93. PubMed ID: 18363870
[TBL] [Abstract][Full Text] [Related]
19. Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells.
Fei M; Hang Q; Hou S; He S; Ruan C
Mol Cell Biochem; 2014 Jan; 386(1-2):177-87. PubMed ID: 24170542
[TBL] [Abstract][Full Text] [Related]
20. The Zyxin-related protein thyroid receptor interacting protein 6 (TRIP6) is overexpressed in Ewing's sarcoma and promotes migration, invasion and cell growth.
Grunewald TG; Willier S; Janik D; Unland R; Reiss C; Prazeres da Costa O; Buch T; Dirksen U; Richter GH; Neff F; Burdach S; Butt E
Biol Cell; 2013 Nov; 105(11):535-47. PubMed ID: 24033704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]